European DO-HEALTH Clinical Trial Aims at Simple, Affordable Interventions to Improve Senior Health
European health care systems, as elsewhere, are striving to meet the challenge of caring for a growing number of seniors. By 2050, the number of people over 65 in the EU will increase by 70 percent, and the number of people over age 80 will grow by 170 percent. Therapeutic interventions that are effective, affordable and well-tolerated in the prevention of chronic disease could have an outstanding impact on public health as a whole and are urgently needed.
Content: eBook, Topic: Clinical Trial Sample Manag..........
Centralized Biobanks are Critical, Especially for Research on Rare Diseases
An Inside Biobanking blog posted on October 11, 2013, "How a Biobank Is Enabling Improved Sarcoma Research", highlighted the need for third party biobanks for researchers investigating rare diseases, and mentioned the sarcoma research biobank as a case in point. Sarcoma research is hindered by the fact that sarcomas are quite rare, with only 15,000 new cases appearing per year in the US. This represents about one percent of the 1.5 million new cancer diagnoses in that country each year.
Topic: Biobanking and Biorepository, Content: Blog